Resources: Affiliate News
Trump’s Medicaid changes offer states new powers to lower drug costs — with a catch
From the article: WASHINGTON — The Trump administration on Thursday unveiled a powerful new tool for states to rein in prescription drug spending. But there’s a catch: States…
Response to Charles Murray on Polygenic Scores
The following is from the full version of the Letter to the Editor of the Wall Street Journal in response to Charles Murray’s op-ed, “Genetics Will Revolutionize…
FDA Approves Cocaine Nasal Spray as Study Casts Doubt on FDA Standards
From the article: On January 13, the pharmaceutical company Lannett Company, Inc. announced that the United States Food and Drug Administration (FDA) approved its New Drug Application to market Numbrino, the…
Drugmakers blast Medicaid block grants
From the article: DRUG INDUSTRY FUMING ABOUT MEDICAID BLOCK GRANTS — The Trump administration's new Medicaid block grant plan would let states exclude coverage of some prescription drugs while…
Trump Administration Unveils a Major Shift in Medicaid
From the article: WASHINGTON — The Trump administration said on Thursday that it would allow states to cap Medicaid spending for many poor adults, a major shift long sought by…
Does ‘no more copays, no more deductibles’ really represent radical health care reform?
From the article: Lost in the shuffle of competing plans for saving health care is the radical call by Democratic presidential candidates Bernie Sanders and Elizabeth Warren for "no…
Politicians are missing the big point on health care
From the article: Polls show that health care is the single most important issue for voters, so it is not surprising that Democratic candidates have been busy releasing policy proposals.…
FDA Drug Approvals Require Less Rigorous Evidence, Study Finds
From the article: An ongoing push to speed new medicines to patients has led to the growth of new Food and Drug Administration programs with relaxed evidence standards for approving…
FDA Approves Drugs Faster Than Ever But Relies On Weaker Evidence, Researchers Find
From the article: The Food and Drug Administration has gotten faster at approving new prescription drugs over the past four decades, but the evidence it relies on in making those…
FDA approval may not be as rigorous as it once was
From the article: Changes in U.S. Food and Drug Administration (FDA) procedures meant to speed approvals for medications may have resulted in less exacting standards, a new analysis suggests.…